| Product Code: ETC7323717 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Clinical Oncology NGS Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Clinical Oncology NGS Market - Industry Life Cycle |
3.4 Ghana Clinical Oncology NGS Market - Porter's Five Forces |
3.5 Ghana Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ghana Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Ghana Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ghana Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Ghana Clinical Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ghana |
4.2.2 Growing awareness about the benefits of Next-Generation Sequencing (NGS) in clinical oncology |
4.2.3 Technological advancements in NGS platforms |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and services |
4.3.2 Limited infrastructure and expertise in clinical oncology NGS in Ghana |
5 Ghana Clinical Oncology NGS Market Trends |
6 Ghana Clinical Oncology NGS Market, By Types |
6.1 Ghana Clinical Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ghana Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ghana Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Ghana Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Ghana Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F |
6.2 Ghana Clinical Oncology NGS Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Ghana Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.2.3 Ghana Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 Ghana Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F |
6.3 Ghana Clinical Oncology NGS Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ghana Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Ghana Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Ghana Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F |
6.4 Ghana Clinical Oncology NGS Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Ghana Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ghana Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Ghana Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F |
7 Ghana Clinical Oncology NGS Market Import-Export Trade Statistics |
7.1 Ghana Clinical Oncology NGS Market Export to Major Countries |
7.2 Ghana Clinical Oncology NGS Market Imports from Major Countries |
8 Ghana Clinical Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing |
8.2 Number of healthcare facilities offering clinical oncology NGS services in Ghana |
8.3 Percentage of oncologists trained in NGS technology in Ghana |
9 Ghana Clinical Oncology NGS Market - Opportunity Assessment |
9.1 Ghana Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ghana Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Ghana Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ghana Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Ghana Clinical Oncology NGS Market - Competitive Landscape |
10.1 Ghana Clinical Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Ghana Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here